This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Medical communications are in a state of transition. Francis Namouk, managing director of Healthware MedComms , a new medical communications and education division of the Healthware Group, tells us more. Where medical communications have historically centred on brand, providers now desire more tailored, science-driven messaging.
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies. The evolution of value in healthcare is a trend that has important implications for communications, particularly because ‘value’ is very much in the eye of the beholder.
This article appears in our digital magazine Deep Dive: Market Access 2021. But traditional payer archetyping is no longer enough. • Read the full article in pharmaphorum’s Deep Dive digital magazine. The post How to improve payer engagement with tailored value communication appeared first on.
Welcome to Delta – the new Fishawack Health magazine. We’ve chosen to focus our first edition of the magazine on a topic close to our hearts, rare diseases. DOWNLOAD OUR DIGITAL MAGAZINE HERE. The post Unpacking rare diseases in the first edition of Delta magazine appeared first on.
Speaking, hearing, and comprehending is how most of us communicate with the outside world, and being unable to do so — or even to do so with difficulty — can be a significant impediment to dealing with others. The post How Effective Are Drugs in Treating Communication Disorders? appeared first on Pharma Mirror Magazine.
The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. The pharma company’s senior vice president for major markets talks about the continued evolution of the industry’s approach to communications and commercialisation.
COVID-19 might have forced pharma to finally fully embrace digital communications, but that doesn’t mean the industry is good at using these platforms yet. Responding to dynamic shifts in value communications. The post Deep Dive: Communications 2020 appeared first on. Subscribe to future issues of Deep Dive.
Ian Dorrian, president of Syneos Health Communications Europe, says COVID-19 has driven “unprecedented disruption” in pharma’s interactions with its customers. There’s no case study for this situation; we need to embrace risk and define a new normal. The post Thriving in COVID-19 with flexible marketing strategies appeared first on.
The company’s senior vice president for major markets (Europe, Canada and Japan) talks about the continued evolution of pharma’s approach to communications and commercialisation. She recently joined the pharmaphorum podcast to discuss the evolution of communications and commercialisation and her work mentoring the female leaders of tomorrow.
There is little doubt that the arrival of COVID-19 changed the game for communication and commercialisation efforts for pharmaceutical companies around the world. Medical communications must adapt to bring the stories behind scientific messages to life, says Healthware MedComms’ Francis Namouk. Subscribe to future issues of Deep Dive.
The integration of artificial intelligence (AI) tools across medical communications is proving to be a transformative development, ushering in increased efficiencies and innovation across the healthcare industry.
However, it’s no secret that the landscape of healthcare communications has undergone a substantial transformation in recent years. For an industry such as pharma, which must adhere to strict legal and regulatory procedures, creating an agile communications strategy can be a complex challenge.
“Because of that, companies are under a lot of pressure to get a return on investment from these meetings.”. • Read the full article in pharmaphorum’s Deep Dive digital magazine. The post How hybrid virtual engagement is accelerating oncology communication appeared first on.
Emma Sutcliffe from NexGen Healthcare Communications looks at how patient insights can bring the invisible challenges of living with a rare condition into plain view. The post Focus on Rare: the invisible burden of rare diseases appeared first on.
After a year of tech-mediated communication, it’s hard to get excited about another screen interaction. Of course, tech can’t take the place of in-person – but a mindful approach to tech can make communication more meaningful. Most of us want to connect in person … to have authentic interactions. But we have to do it with intent.
Through her role as head of the Patient Voice Consortium at Syneos Health®, McDonough has seen first-hand how pharma companies large and small have attempted to build patient-centricity in the development programmes, with varying results. • Read the full article in pharmaphorum’s Deep Dive digital magazine.
The publication will also look at the pandemic’s impact on communications between the industry and doctors. The post The post-pandemic evolution of pharma-doctor digital interactions appeared first on.
This article appears in our free digital magazine Deep Dive: Market Access 2021. There are plenty of rare disease drugs that aren’t so lucky, though, and Sanders says that in order for other treatments to avoid metreleptin’s early reimbursement difficulties more communication between every stakeholder at every stage is vital.
Mike Dixon, CEO of the Healthcare Communications Association, discusses the biggest challenges facing the sector during and after COVID, from digital innovation to talent and sustainability. The post The right people and the right environment for innovative comms appeared first on.
This collaboration marks a significant milestone in digital communication within the healthcare industry. Driving Success in Pharma Communication The partnership between Viseven and SpotMe creates a unique point of view on the HCP engagement and B2B event organization.
Exosomes have another essential function, and that would be intercellular communication. The enhanced communication means that exosomes can facilitate the transfer of RNA, cytokines, growth factors, and specific proteins like keratin. All of these are necessary for the skin to rejuvenate itself.
The post Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service appeared first on Pharma Mirror Magazine. Todokusuri EXPRESS responds to the needs of the.
The post Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam appeared first on Pharma Mirror Magazine. ” This is the third year, after similar projects in Thailand in fiscal year. ” This is the third year, after similar projects in Thailand in fiscal year. .”
According to a recent Medscape survey of over 5,500 physicians in the EU found 86% had increased their consumption of medical content online during the pandemic. • Read the full article in pharmaphorum’s Deep Dive digital magazine. The post It’s time to rethink the physician-pharma relationship appeared first on.
advertisements in published journals, magazines, other periodicals, and newspapers, and advertisements broadcast through media such as radio, television, and telephone communication systems”). l)(1) (e.g.,
In the rapidly changing field of medicine, effective communications are essential to ensuring that innovations are cascaded out across the health system. New research from M3 highlights the need for pharma to adapt their communication efforts to help ease the burden placed on doctors.
Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications. This episode also appears, in an abridged version, in the latest issue of our digital magazine Deep Dive.
Sales Enablement Omnichannel is a customer-centric approach that seamlessly integrates multiple communication The post How to Leverage Omnichannel & Sales Enablement Technologies for Pharmaceutical Sales Success appeared first on Pharma Mirror Magazine.
SmiLe Incubator’s angel investment company, SmiLe Inject Capital, invests 2 MSEK in Call Knut, an incubator company that is developing a voice robot- based service using AI and ordinary phone calls as a complement in communicating with and caring for elderly people living on their own. Call Knut’s service is based on.
But launch really is the key moment, when real-time, real-world feedback starts to come online and the starting pistol is fired for implementing – and adapting – the prepared strategy. • Read the full article in pharmaphorum’s Deep Dive digital magazine.
Today’s oncology launch landscape is highly saturated and competitive, cumulatively presenting significant challenges, particularly for small and emerging companies to gain traction with medical and scientific communications that inform key stakeholders about their oncology therapies.
Acknowledging and amplifying these voices is essential for pharma companies looking to enter the market but communicating with such a passionate and informed group can be challenging. Rare diseases are notoriously heterogeneous,” says Dr Emma Lemon, who leads the Medical practice at AXON, a global healthcare communications agency.
Though the market access team, GHEORE team, and scientific data team are separate, they can work cross-functionally with one another and consult with each other for input or reach out for expertise as needed. • Read the full article in pharmaphorum’s Deep Dive digital magazine.
Global communications consultancy Ketchum has announced the hire of Neera Chaudhary as president of North America. . Today, Ketchum offers extensive vertical expertise in 12 industries and 16 communications specialties. Chaudhary most recently served as global president of healthcare at Golin, a role she has held since 2017.
How to improve payer engagement with tailored value communication. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Value can mean different things to different payers.
Physicians, patients, and caregivers are all tapping into the power of social media to communicate with one another and increase awareness about certain issues that are important to them. In our line of work, there is another type to watch out for – the healthcare influencer.
A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency. The post Patients want to be heard. Is pharma listening? appeared first on.
When combined with Fishawack Health’s existing omnichannel services, which span medical communications, commercial, and consulting capabilities , life science companies will have the opportunity to access and benefit from an unrivaled offering that will help them precisely understand and engage stakeholders. Download Delta magazine.
This has ultimately led to the development of virtual patient simulations (VPS), which have become one of the most impactful ways clinicians can learn. • Read the full article in pharmaphorum’s Deep Dive digital magazine. The post The tools and techniques making virtual patient simulations more realistic than ever appeared first on.
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of stakeholders earlier than you think. Download the magazine.
Partner at Rebound Communications, a firm that specializes in Commercial Acceleration for tech and data companies in life sciences and healthcare. Rebound was recently recognized by Inc Magazine as one of America’s 5000 fastest-growing private companies, coming in at #702 on the list with 893% growth over the past three years.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content